Eight isolates of canine distemper virus (CDV) were obtained from seven dogs suffering from distemper by co-cultivation of their mononuclear cells with a marmoset B lymphoblastoid cell line, B95a. Six of the seven dogs had received one or more vaccinations. All of the isolates readily proliferated in B95a cells, but were not completely neutralized by anti-CDV canine plasma, which had high neutralizing activity against the Onderstepoort laboratory strain of CDV. Furthermore, different reactivities of monoclonal antibodies (MAbs) against CDV were observed between the field isolates and laboratory or vaccine strains of CDV in immunofluorescence studies. Immunoprecipitation analysis using MAbs detected the haemagglutinin protein of each new field isolate as 69K, 75K and 155K forms, and the fusion protein as 64K and 65K forms; the corresponding proteins of the Onderstepoort strain were detected as 75K and 61K proteins respectively. It is apparent from these results that the new field isolates of CDV have very different antigenic properties from the Onderstepoort vaccine strain.
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Canine distemper virus (CDV), together with measles virus (MV), rinderpest virus (RPV), peste des petits ruminants virus, phocine distemper virus, porpoise morbillivirus and dolphin morbillivirus, belongs to genus Morbillivirus in the family Paramyxoviridae (Pringle, 1991; Barrett et al., 1993; Visser et al., 1993) . CDV causes an acute to subacute contagious systemic disease with a high mortality rate in dogs and in other carnivores throughout the world. Affected dogs show gastrointestinal and respiratory clinical signs, and frequently develop clinical signs in the central nervous system (CNS). The disease has been controlled for many years using live attenuated vaccines (Appel, 1987) . Recently however, we have found many cases of vaccinated dogs showing typical clinical signs of CDV infection. In some cases the dogs developed CNS signs without first showing any gastrointestinal or respiratory signs. It was not clear whether this is due to vaccination failure, or to the appearance of a new virulent virus in the field that could escape vaccine-induced immunity. In this study we isolated CDV from mononuclear cells of peripheral blood and cerebrospinal fluid (CSF) of some affected dogs by co-cultivation with B95a cells, which were previously shown to be highly susceptible to infection with MV (Kobune et al., 1990; Forthal et al., 1993) , RPV (Kobune et al., 1991) and CDV (Kai et at., 1993) . It has been established that CDV is carried into the CNS of infected dogs via infected lymphocytes (Summers et al., 1978) . The new isolates were characterized serologically and biologically and compared with several laboratory and vaccine strains of CDV.
B95a cells are an adherent derivative of B95-8 cells, an Epstein-Barr virus-transformed marmoset B lymphoblast cell line (Kobune et al., 1990) . The cells were propagated in RPMI 1640 medium containing 5 % fetal calf serum (FCS) and maintained in RPMI 1640 supplemented with 1% FCS at 37 °C in a 5% CO2 humidified atmosphere. Vero cells were propagated in Eagle's minimum essential medium (EMEM) containing 5 % FCS and maintained in EMEM supplemented with 1% FCS. In a preliminary experiment, a newborn puppy, which did not have anti-CDV neutralizing maternal antibody, was infected intravenously (i.v.) with 2 x 104 TCIDs0 of the Onderstepoort strain. At intervals after inoculation, a small amount of blood was collected for virus isolation and determination of anti-CDV neutralizing antibody titre in the serum. The separated mononuclear cells were co-cultivated with either B95a cells or Vero cells for virus isolation. On day 2 of cocultivation of the sample collected on day 8 postinoculation (p.i.) c.p.e, appeared in B95a cells, whereas no c.p.e, was observed in Vero cells, in agreement with our previous results (Kai et al., 1993) . Further virus isolation from clinical specimens was then only attempted using B95a cells. To determine the neutralizing antibody titre, inactivated plasma samples of dogs were diluted twofold in RPMI 1640 medium and were mixed with an equal volume of medium containing 100 TCIDs0/ml of the Onderstepoort strain or field isolates of CDV, and incubated at 37 °C for 1 h. The mixture was then inoculated onto B95a cells. The neutralizing antibody titre of the inactivated plasma was determined by 50 % inhibition of c.p.e, induced by the Onderstepoort strain and field isolates of CDV after incubation for 7 days. The neutralizing antibody titres were below detectable levels (less than 5) at 8 and 15 days p.i. in the experimentally vaccinated puppy, but titres of 100 and 160 were found at 22 and 29 days p.i. respectively. We failed to re-isolate CDV from mononuclear cells at this time, which was in accordance with the results reported by Appel (1987) . The inactivated plasma from this experimentally vaccinated puppy, which had high neutralizing activity (greater than 1280) against the Onderstepoort strain of CDV, was used as a positive control. Specimens were collected from sick dogs showing clinical signs suspected to be due to CDV infection from November 1991 to March 1992. During that period we attempted virus isolations from 20 clinical specimens from 17 dogs. Three of them were CSF and the others were peripheral blood samples (Table 1) . Mononuclear cells were separated from heparinized blood on FicollPaque (Pharmacia) by centrifugation at 1500 r.p.m, for 45 min. Mononuclear cells from the CSF of dogs that developed severe clinical CNS signs were obtained by centrifugation at 1500r.p.m. for 10min. The mononuclear cells were co-cultivated with B95a ceils in RPMI 1640 supplemented with 1% FCS and passaged daily.
When the B95a cells exhibited c.p.e., they were harvested and disrupted by three cycles of freezing and thawing followed by sonication. After centrifugation at 3000r.p.m. for 10rain, the supernatant was reinoculated onto B95a cells for propagation of the virus. Viruses at the third passage stage in B95a cells were used as field isolates of CDV in this study. The Onderstepoort vaccine strain was similarly passaged three times in B95a cells and used as a standard laboratory strain for comparison with the field isolates. In all, eight new CDV isolates were obtained from seven dogs. With these viruses c.p.e, appeared in B95a cells from days 2 to 10. The c.p.e, was characterized by the formation of swollen and rounded cells and syncytia. The size of the syncytial cells varied depending on the virus isolate (data not shown).
For multistep growth experiments, virus isolates (200 TCIDs0) were inoculated onto monolayer cultures of B95a cells (approximately 5 x 105/well) grown in 12-well culture plates and the cell cultures were harvested at intervals and processed as described above. The virus titres of the cell extracts and the culture supernatants were determined in B95a cells using microtitre plates. Six of the new isolates and the Onderstepoort strain proliferated rapidly in B95a cells, and high virus titres were obtained from both the cell extracts and the culture supernatants, especially in the case of isolate UTpMiyazaki. However, two other isolates, UTp-Edogawa and UTc-Edogawa obtained from the same dog, did not grow as well and the maximum titres of virus in the cell extracts were 10-fold lower than those from any of the other isolates. There was also a difference in the time of appearance of c.p.e, relative to the production of infectious virus with the UTc-Edogawa isolate. Infectious virus was produced before the onset of c.p.e., whereas with the other isolates the two corresponded in their time of appearance. Mutations in the fusion protein (F) and haemagglutinin (H) genes, leading to an alteration in fusion function, might explain this delayed c.p.e. Sequence variations between the vaccine and recent field isolates of measles virus have been shown (Rota et al., 1992) and in patients with subacute sclerosing panencephalitis many differences have been found between the virus present in infected brain material and the wild-type virus sequence (Cattaneo et al., 1989; Cattaneo & Rose, 1993; Schmid et al., 1992) . Neutralizing antibody titres in the inactivated plasma of each dog were determined as described above. The positive control plasma obtained from the experimentally vaccinated puppy, which had relatively high neutralizing activity against the Onderstepoort vaccine strain (1280), failed to neutralize any of the field isolates (Table 2 ). There were differences in abilities of the plasma of each dog to neutralize the Onderstepoort strain and the different field isolates. We also tested a neutralizing monoclonal antibody (MAb), d-7, which recognizes an epitope on the H protein of the FXNO strain of CDV . The MAb showed no neutralizing activity (less than 5) against any of the isolates (data not shown). These results indicated that the new field isolates had lost an epitope present in the vaccine strain and could escape neutralization by MAb d-7.
Several MAbs directed against different virus proteins produced using the CDV FXNO strain were used for both indirect immunofluorescence analysis (IFA) and immunoprecipitation. These were MAb d-7, specific to the H protein, MAbs k-l, f-7, b-8, a-3 and a-8, specific to the F protein and MAbs f-5, c-5 and h-6, specific to the nucleocapsid (N) protein . Another MAb (B-l), produced against the H protein of RPV and which cross-reacts with the CDV H protein, was also used . In addition to the field isolates, we used eight laboratory and vaccine strains of CDV for IFA. The laboratory strains DFE, HK, YSA-TC, Hg94TC, Onderstepoort, FXNO and Fromm had been passaged in chorioallantoic membranes and chick and/or duck embryo fibroblasts and were finally passaged twice in Vero cells. Strain Snyder Hill was passaged many times through dog brain and finally twice in Vero cells. The origins and histories of these strains have been described previously (Hirayama et al., 1986) . These viruses were inoculated onto monolayer cultures of B95a or Vero cells grown in Lab-tek chamber slides (Nunc InterMed). When c.p.e, developed, cells were fixed with acetone and reacted with diluted ascitic fluids containing the MAbs as the first antibody. Fluorescein isothiocyanate-conjugated rabbit antimouse IgG (Cappel Laboratories) was used as the second antibody. Although MAb B-1 (anti-RPV H protein) recognized all the isolates, MAb d-7 (anti-CDV H protein) did not react with any of the new isolates but reacted with all the laboratory strains. MAbs, k-l, f-7 and a-3 against the CDV F protein and MAb f-5 against the CDV N protein also recognized all the isolates. MAb a-8 (anti-CDV F protein) recognized only three of the field isolates, whereas MAb b-8 (anti-CDV F protein) and MAbs h-6 and c-5 (anti-CDV N protein) did not bind to any of the new isolates. In contrast, all of the Short communication (Table 3) . For immunoprecipitation, B95a cells grown in 60 mm diameter plastic dishes were infected with CDV strains. At the onset of c.p.e., cells were washed twice with methionine-free RPMI 1640 and incubated at 37 °C in the medium for 1 h. The cells were then labelled with 80 gCi/ml of [3~S]methionine (Du Pont NEN) for 8 to 12h in fresh methionine-free medium. The radiolabelling, preparation of cell lysates, immunoprecipitation and SDS-PAGE were performed as described by Sato et al. (1988) with some modifications. In this study, the cell lysates were reacted with MAbs f-7 or B-l, to detect envelope proteins, for 3 h at 4 °C and electrophoresis was performed with 5 to 10 % or 7.5 to 15% gradient polyacrylamide gels. Rainbow [14C]-methylated protein M r markers (Amersham) were used for size calibration. For visualization, a Bio-Imaging Analyzer (BAS2000; Fuji) was used. The F 0 form of the F protein was detected as 64K and 65K proteins and the difference in the electrophoretic mobility between the two forms was calculated to be, on average, 1-5K in all the field isolates. Only a 61K F 0 protein was detected in the Onderstepoort strain (Fig. l a) . The immunoprecipitated H protein was detected as 69K, 75K and 155K forms in all the field isolates, but only a single 75K form of the protein was detected in the Onderstepoort strain (Fig. 1 b) . The signal in lane 9 (Onderstepoort strain) was quite weak even though a 100-fold greater volume of cell lysate was used compared to the other samples. Highly sensitive image enhancement analysis of lane 9 is shown in lane 11, but 69K and 155K proteins were still not detectable. The affinity of anti-RPV MAb B-1 for the H protein of the Onderstepoort strain might be lower than for that of the field isolates.
Since the first isolation of CDV was made in 1905 by CarrY, many researchers have attempted to use primary cell cultures and established cell lines for isolation and cultivation of the virus. In most non-lymphoid cell lines however, CDV rapidly loses its virulence and, after several passages, avirulent virus becomes a major population (for reviews see Appel, 1987; Appel & Gillespie, 1972) . Recently, Kobune et al. (1990 Kobune et al. ( , 1991 reported that B95a cells were highly susceptible to infection with MV and RPV and that both of these viruses could maintain their virulence for laboratory animals when they were serially passaged in B95a cells. We have demonstrated that B95a cells are also useful for the isolation of CDV from clinical material (Kai et al., 1993) and that isolation of the virus in these cells can be performed much more rapidly than in Vero cells.
Plasma with a high neutralizing titre against the Onderstepoort vaccine strain differed in its ability to neutralize the field isolates. This indicated that there were alterations in the neutralizing epitopes of field isolates compared to the previous laboratory or vaccine strains of CDV. This was further demonstrated by differences in reactivities with a panel of MAbs in IFA. In particular, none of the isolates reacted with an anti-H protein MAb (d-7), which had high neutralizing activity and had a protective effect against lethal CDV infection in mice . All of the new isolates reacted with the anti-RPV H protein MAb (B-l), which also cross-reacts with all the other strains of MV and CDV tested . This conservation of a morbillivirus cross-reactive epitope but the loss of a Rima, 1983 ). The 75K protein, which was detected both in new field isolates and in the Onderstepoort vaccine strain in this study, is probably equivalent to the mature H protein described above. The 69K and 155K proteins, which were detected only in field isolates, were presumed to be the non-glycosylated precursor and a dimer form of the H protein respectively. It is not clear why the dimer was not completely converted to the monomer under the reducing conditions used in PAGE. Again, sequencing studies may help resolve these discrepancies. Further virus isolations from other geographical locations and immunological and genetic characterization of these isolates should provide a better understanding of the natural variation and pathogenesis of CDV and possibly indicate better means of prophylaxis against the disease in dogs.
